Resmed (NYSE: RMD) announced today that it received FDA clearance for its Smart Comfort personalized therapy comfort settings ...
A new study published in the Journal of the American Medical Association found that obstructive sleep apnea could be linked ...
Resmed has received clearance from the U.S. Food and Drug Administration (FDA) for an artificial intelligence (AI)-enabled ...
A new study published in npj Aging provides compelling evidence that untreated obstructive sleep apnea (OSA) accelerates ...
Resmed believes its artificial intelligence-powered approach to personalizing the settings of its connected CPAP machines can lead to better sleep for people with obstructive apnea. | Resmed believes ...
SAN DIEGO, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced it has ...
Untreated sleep apnea may play a role in Parkinson's disease development, a new study suggests, but early CPAP therapy shows protective benefits.
Sleep apnea, a condition affecting more than 12 million Americans, can lead to a host of health problems including heart disease. But, a new treatment containing ingredients derived from cannabis is ...
A new study found that getting CPAP treatment within the first two years of a sleep apnea diagnosis reduced the risk of ...
A study of 11 million people found those who used CPAP machines to treat the disorder were less likely to develop the incurable neurological disease.
Emilio also has Down syndrome. Individuals with Down syndrome are much more likely to have obstructive sleep apnea (OSA) than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback